Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,41 USD | +6,16% | +2,99% | +135,93% |
17/04 | Stoke Therapeutics benoemt Jason Hoitt tot Chief Commercial Officer | CI |
28/03 | Sectorupdate: Gezondheidszorgaandelen stijgen donderdag premarket | MT |
Omzet 2024 * | 12,37 mln. 11,56 mln. | Omzet 2025 * | 15,76 mln. 14,74 mln. | Marktkapitalisatie | 647 mln. 605 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -116 mln. -108 mln. | Nettowinst (verlies) 2025 * | -138 mln. -129 mln. | EV/omzet 2024 * | 36,2 x |
Nettoliquiditeiten 2024 * | 199 mln. 186 mln. | Nettoliquiditeiten 2025 * | 146 mln. 137 mln. | EV/omzet 2025 * | 31,8 x |
K/w-verhouding 2024 * |
-5,38
x | K/w-verhouding 2025 * |
-4,92
x | Werknemers | 110 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,61% |
1 dag | +6,16% | ||
1 week | +2,99% | ||
Lopende maand | -8,07% | ||
1 maand | +20,60% | ||
3 maanden | +152,24% | ||
6 maanden | +258,67% | ||
Lopend jaar | +135,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward Kaye
CEO | Chief Executive Officer | 75 | 01-10-17 |
Isabel Aznarez
FOU | Founder | 52 | 01-06-14 |
Stephen Tulipano
DFI | Director of Finance/CFO | 65 | 01-03-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 01-09-15 |
Edward Kaye
CEO | Chief Executive Officer | 75 | 01-10-17 |
Seth Harrison
CHM | Chairman | 63 | 01-07-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - | |
0.02% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 12,41 | +6,16% | 895 902 |
25-04-24 | 11,69 | +0,26% | 564 531 |
24-04-24 | 11,66 | +3,64% | 1 474 467 |
23-04-24 | 11,25 | 0,00% | 637 368 |
22-04-24 | 11,25 | -6,64% | 1 290 253 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+135,93% | 609 mln. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |